{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T16:29:35Z","timestamp":1761323375203},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1990,5,1]],"date-time":"1990-05-01T00:00:00Z","timestamp":641520000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur. J. Clin. Microbiol. Infect. Dis."],"published-print":{"date-parts":[[1990,5]]},"DOI":"10.1007\/bf01973741","type":"journal-article","created":{"date-parts":[[2005,8,2]],"date-time":"2005-08-02T19:19:39Z","timestamp":1123010379000},"page":"345-347","source":"Crossref","is-referenced-by-count":19,"title":["Isolation of fluoroquinolone-resistantEscherichia coli andKlebsiella pneumoniae from an infected hickman catheter"],"prefix":"10.1007","volume":"9","author":[{"given":"M.","family":"L\u00f3pez-Brea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Alarc\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01973741_CR1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000238309","volume":"31","author":"W Cullmann","year":"1985","unstructured":"Cullmann W, Stieglitz M, Baars B, Opferkuch W Comparative evaluation of recently developed quinolone compounds \u2014 with a note on the frequency of resistant mutants. Chemotherapy 1985, 31: 19\u201328.","journal-title":"Chemotherapy"},{"key":"BF01973741_CR2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/jac\/19.4.449","volume":"19","author":"PB Fernandes","year":"1987","unstructured":"Fernandes PB, Hanson CW, Stamm JM, Vojtko C, Shipkowitz N, Martin ET The frequency of in vitro resistance development to fluoroquinolones and the use of murine pyelonephritis model to demonstrate selection of resistance in vivo. Journal of Antimicrobial Chemotherapy 1987, 19: 449\u2013465.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01973741_CR3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1128\/AAC.28.4.581","volume":"28","author":"JS Wolfson","year":"1985","unstructured":"Wolfson JS, Hooper DC The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro. Antimicrobial Agents and Chemotherapy 1985, 28: 581\u2013586.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01973741_CR4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/jac\/20.3.295","volume":"20","author":"JA Raeburn","year":"1987","unstructured":"Raeburn JA, Govan RW, McCrae WM, Greening A, Collier PS, Hodson E, Goodchild C Ciprofloxacin therapy in cystic fibrosis. Journal of Antimicrobial Chemotherapy 1987, 20: 295\u2013296.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01973741_CR5","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(86)90937-2","volume":"i","author":"B Scully","year":"1986","unstructured":"Scully B, Neu H, Parry M, Mandell W Oral ciprofloxacin therapy of infections duePseudomonas aeruginosa. Lancet 1986, i: 819\u2013822.","journal-title":"Lancet"},{"issue":"Supplement 4A","key":"BF01973741_CR6","first-page":"303","volume":"82","author":"JL Ryan","year":"1987","unstructured":"Ryan JL, Berenson CS, Greco TP, Mangi RJ, Sims M, Thornton GF, Andriole VT Oral ciprofloxacin in resistant urinary tract infections. American Journal of Medicine 1987, 82, Supplement 4A: 303\u2013306.","journal-title":"American Journal of Medicine"},{"key":"BF01973741_CR7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/jac\/19.1.65","volume":"19","author":"DI Limb","year":"1987","unstructured":"Limb DI, Dabbs DJ, Spencer RC In vitro selection of bacteria resistant to the 4-quinolone agents. Journal of Antimicrobial Chemotherapy 1987, 19: 65\u201371.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01973741_CR8","first-page":"35","volume-title":"Quinolone antimicrobial agents","author":"GM Eliopoulos","year":"1989","unstructured":"Eliopoulos GM, Eliopoulos CT Quinolone antimicrobial agents: activity in vitro. In: Wolfson JS, Hooper DC (ed): Quinolone antimicrobial agents. American Society for Microbiology, Washington DC, 1989, p. 35\u201369."},{"key":"BF01973741_CR9","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/BF01964247","volume":"7","author":"MJ Haverkom","year":"1988","unstructured":"Haverkom MJ Ciprofloxacin therapy of respiratory tract infection withPseudomonas aeruginosa. European Journal of Clinical Microbiology and Infectious Diseases 1988, 7: 661\u2013664.","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"key":"BF01973741_CR10","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/infdis\/157.4.743","volume":"157","author":"JW Ogle","year":"1988","unstructured":"Ogle JW, Reller LB, Vasil ML Development of resistance inPseudomonas aeruginosa to imipenem, norfloxacin and ciprofloxacin during therapy: proof provided by typing with a DNA probe. Journal of Infectious Diseases 1988, 157: 743\u2013748.","journal-title":"Journal of Infectious Diseases"},{"key":"BF01973741_CR11","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/BF02017607","volume":"3","author":"D Milatovic","year":"1987","unstructured":"Milatovic D, Braveny I Development of resistance during antibiotic therapy. European Journal of Clinical Microbiology 1987, 3: 234\u2013244.","journal-title":"European Journal of Clinical Microbiology"},{"key":"BF01973741_CR12","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/jac\/18.6.771","volume":"18","author":"BS Azadian","year":"1986","unstructured":"Azadian BS, Bending JW, Samson DM Emergence of ciprofloxacin-resistantPseudomonas aeruginosa after combined therapy with ciprofloxacin and amikacin. Journal of Antimicrobial Chemotherapy 1986, 18: 771.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01973741_CR13","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jac\/23.4.475","volume":"23","author":"LJ Piddock","year":"1989","unstructured":"Piddock LJ, Wise R Mechanisms of resistance to quinolones and clinical perspectives. Journal of Antimicrobial Chemotherapy 1989, 23: 475\u2013483.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01973741_CR14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(85)90083-2","volume":"ii","author":"ST Chapman","year":"1985","unstructured":"Chapman ST, Speller DCE, Reeves DS Resistance to ciprofloxacin. Lancet 1985, ii: 39.","journal-title":"Lancet"},{"issue":"Supplement 5A","key":"BF01973741_CR15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/0002-9343(89)90010-7","volume":"87","author":"LM Fisher","year":"1989","unstructured":"Fisher LM, Lawrence JM, Josty IC, Hopewell R, Margerrison EEC, Cullin ME Ciprofloxacin and the fluoroquinolones: new concepts on the mechanism of action and resistance. American Journal of Medicine 1989, 87, Supplement 5A: 2\u20138.","journal-title":"American Journal of Medicine"},{"key":"BF01973741_CR16","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3109\/00365548709032422","volume":"19","author":"M Rylander","year":"1987","unstructured":"Rylander M, Norrby SR, Sw\u00e4rd R Norfloxacin versus cotrimoxazole for treatment of urinary tract infections in adults: microbiological results of a coordinated multicentre study. Scandinavian Journal of Infectious Diseases 1987, 19: 551\u2013557.","journal-title":"Scandinavian Journal of Infectious Diseases"},{"key":"BF01973741_CR17","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1128\/AAC.31.10.1640","volume":"31","author":"H Aoyama","year":"1987","unstructured":"Aoyama H, Sato K, Kato T, Hirai K, Mitsuhashi S Norfloxacin resistance in a clinical isolate ofEscherichia coli. Antimicrobial Agents and Chemotherapy 1987, 31: 1640\u20131641.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01973741_CR18","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1128\/AAC.30.5.777","volume":"30","author":"K Sato","year":"1986","unstructured":"Sato K, Inoue Y, Fujii T, Aoyama H, Inoue M, Mitsuhashi S Purification and properties of DNA gyrase from a fluoroquinolone-resistant strain ofEscherichia coli. Antimicrobial Agents and Chemotherapy 1986, 30: 777\u2013780.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01973741_CR19","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/infdis\/153.3.617","volume":"153","author":"C Sanders","year":"1986","unstructured":"Sanders C, Watanakunakorn C Emergence of resistance to beta-lactams, aminoglycosides and quinolones during combination therapy for infection due toSerratia marcescens. Journal of Infectious Diseases 1986, 153: 617\u2013619.","journal-title":"Journal of Infectious Diseases"},{"key":"BF01973741_CR20","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1128\/AAC.33.5.785","volume":"33","author":"K Fujimaki","year":"1989","unstructured":"Fujimaki K, Fujii T, Aoyama H, Sato K, Inoue Y, Inoue M, Mitsuhashi S Quinolone resistance in clinical isolates ofSerratia marcescens. Antimicrobial Agents and Chemotherapy 1989, 33: 785\u2013787.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01973741_CR21","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(85)92343-8","volume":"i","author":"SM Crook","year":"1985","unstructured":"Crook SM, Selkon JB, McLardy-Smith PD Clinical resistance to long-term oral ciprofloxacin. Lancet 1985, i: 1275.","journal-title":"Lancet"},{"key":"BF01973741_CR22","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1128\/AAC.32.8.1285","volume":"32","author":"M Kresken","year":"1988","unstructured":"Kresken M, Wiedemann B Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin. Antimicrobial Agents and Chemotherapy 1988, 32: 1285\u20131288.","journal-title":"Antimicrobial Agents and Chemotherapy"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01973741.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01973741\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01973741","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T14:20:15Z","timestamp":1557757215000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01973741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,5]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1990,5]]}},"alternative-id":["BF01973741"],"URL":"https:\/\/doi.org\/10.1007\/bf01973741","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,5]]}}}